SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )*

Similar documents
SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Rule 13d-102)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

Floor & Décor Holdings, Inc. (Name of Issuer)

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

ShotSpotter, Inc. (Name of Issuer)

Main Street Capital Corp.

Everi Holdings Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

Silvercrest Asset Management Group Inc. (Name of Issuer)

American Midstream Partners, LP (Name of Issuer)

Taubman Centers, Inc. (Name of Issuer)

Spark Therapeutics, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

Propetro Holding Corp. (Name of Issuer)

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

American Midstream Partners, LP (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

Inventergy Global, Inc (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

Realogy Holdings Corp.

SECURITIES AND EXCHANGE COMMISSION Washington, DC SCHEDULE 13G (Rule 13d-102)

Recro Pharma, Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Amendment No. ) Under the Securities Exchange Act of 1934

Common Stock, par value $0.01 per share (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Rosehill Resources Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

ACCESS INTEGRATED TECHNOLOGIES INC

Alliqua BioMedical, Inc.

Limbach Holdings, Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

united StateS SeCuritieS and exchange COMMiSSiOn Washington, D.C SCHeDuLe 13g

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

ECO-STIM ENERGY SOLUTIONS, INC. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Signet Jewelers (Name of Issuer)

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

SCHEDULE 13G* (Rule 13d-102) Corbus Pharmaceuticals Holdings, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Videocon d2h Limited (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Limbach Holdings, Inc (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO.

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment 2)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

Canada Goose Holdings Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

KAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer)

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. KLR Energy Acquisition Corp.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

BRIDGEPOINT EDUCATION, INC. (Name of Issuer)

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

KINGSTONE COMPANIES, INC.

YatraOnline,Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C

Vascular Biogenics Ltd.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

PENN VIRGINIA CORPORATION (Name of Issuer)

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934.

USANA HEALTH SCIENCES, INC. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

Transcription:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (Name of Issuer) Series A Common Stock, no par value (Title of Class of Securities) 21240E105 (CUSIP Number) May 8, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: x Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 10 Pages

CUSIP No. 21240E105 1. Names of Reporting Persons INCA Latin American Fund, LP 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER 7,575,200 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 7,575,200 8. SHARED DISPOSITIVE POWER 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 7,575,200 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 0.9% 12. Type of Reporting Person (See Instructions) PN * Ownership information above is as of the close of business on July 17, 2017, the business day before the filing of this Schedule 13G. Page 2 of 10 Pages

CUSIP No. 21240E105 1. Names of Reporting Persons INCA Investments, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER 54,266,600 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 54,266,600 8. SHARED DISPOSITIVE POWER 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 54,266,600 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.2% 12. Type of Reporting Person (See Instructions) OO * Ownership information above is as of the close of business on July 17, 2017, the business day before the filing of this Schedule 13G. Page 3 of 10 Pages

CUSIP No. 21240E105 1. Names of Reporting Persons INCA Management, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER 7,575,200 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 7,575,200 8. SHARED DISPOSITIVE POWER 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 7,575,200 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 0.9% 12. Type of Reporting Person (See Instructions) OO * Ownership information above is as of the close of business on July 17, 2017, the business day before the filing of this Schedule 13G. Page 4 of 10 Pages

CUSIP No. 21240E105 1. Names of Reporting Persons Fernando Donayre 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) x (b) 3. SEC Use Only 4. Citizenship or Place of Organization United States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER 54,266,600 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 54,266,600 8. SHARED DISPOSITIVE POWER 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 54,266,600 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.2% 12. Type of Reporting Person (See Instructions) IN * Ownership information above is as of the close of business on July 17, 2017, the business day before the filing of this Schedule 13G. Page 5 of 10 Pages

Item 1. (a) (b) The name of the issuer is Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (the Issuer ). The principal executive offices of the Issuer are located at Av. Antonio Dovalí Jaime No. 70, 13 Floor, Tower B, Colonia Zedec Santa Fe, United Mexican States, Mexico City, 01210. Item 2. (a) This statement (this Statement ) is being filed by: (1) INCA Latin American Fund, LP, a Delaware limited partnership (the Fund ); (2) INCA Investments, LLC, a Delaware limited liability company (the InvestmentManager ); (3) INCA Management, LLC, a Delaware limited liability company (the GeneralPartner ); and (4) Fernando Donayre (all of the foregoing, collectively, the ReportingPersons ). The Fund is a private investment vehicle and directly owns 7,575,200 of the shares of Series A Common Stock reported in this Statement, with the remaining 46,691,400 shares of Series A Common Stock held in separately managed accounts ( SMAs ) managed by the Investment Manager. The Investment Manager is the investment manager to the Fund and the SMAs. The General Partner is the general partner of the Fund. Mr. Donayre is Managing Member of the Investment Manager and the General Partner and is the Portfolio Manager for the Fund and the SMAs. The Investment Manager, the General Partner and Mr. Donayre may be deemed to beneficially own the shares of Series A Common Stock owned directly by the Fund and the SMAs. Each Reporting Person disclaims beneficial ownership with respect to any shares of Series A Common Stock other than those owned directly by such Reporting Person. (b) The principal business office of the Reporting Persons is 8950 SW 74th Court, Suite 2101, Miami, Florida 33156. (c) (d) For citizenship information see Item 4 of the cover page of each Reporting Person. This Statement relates to the Series A Common Stock, no par value, of the Issuer (the SeriesACommonStock ). (e) The CUSIP Number of the Common Stock is 21240E105. Page 6 of 10 Pages

Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-u.s. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-u.s. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership. See Items 5-9 and 11 on the cover page for each Reporting Person, and Item 2, which information is given as of close of business on July 17, 2017, the business day before the filing of this Statement. As of the Event Date of May 8, 2017, the Fund directly owned 5,532,000 shares of Series A Common Stock and the SMAs directly owned 38,613,580 shares of Series A Common Stock, collectively amounting to 44,145,580 shares of Series A Common Stock and representing 5.0% of all of the outstanding shares of Series A Common Stock. The percentage ownership of each Reporting Person is based on 877,856,206 shares of Series A Common Stock outstanding as of December 31, 2016, as reported by the Issuer in its Form 20-F filed on April 28, 2017. Pursuant to the Issuer s bylaws, shares of Series A Common Stock can be directly owned only by Mexican individuals or entities controlled by Mexican individuals. As a result, the Fund and the SMAs hold American Depositary Shares ( ADSs ), with each ADS representing ten (10) Ordinary Participation Certificates ( CPOs ), and with each CPO representing a financial interest in one share of Series A Common Stock. None of the Reporting Persons has voting rights with respect to the ADSs held by such Reporting Person; accordingly, the filing of this Statement may not be required. However, in the event that the ADSs were transferred to a Mexican individual or entity controlled by Mexican individuals, and such new holder(s) held shares of Series A Common Stock directly, such new holder(s) would have voting power over such shares of Series A Common Stock. Accordingly, the Reported Persons have elected to file this Statement out of an abundance of caution. Page 7 of 10 Pages

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. See Exhibit 1. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. (a) (b) (c) Not applicable. Not applicable. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Page 8 of 10 Pages

SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: July 18, 2017 Fernando Donayre INCA Investments, LLC INCA Management, LLC INCA Latin American Fund, LP By: /s/ Fernando Donayre Fernando Donayre, for himself and as Managing Member of the Investment Manager and the General Partner (for itself and the Fund) Page 9 of 10 Pages

EXHIBIT INDEX Exhibit No. Document 1 Joint Filing Agreement Page 10 of 10 Pages

Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Series A Common Stock, no par value, of Controladora Vuela Compañía de Aviación, S.A.B. de C.V., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement. Dated: July 18, 2017 Fernando Donayre INCA Investments, LLC INCA Management, LLC INCA Latin American Fund, LP By: /s/ Fernando Donayre Fernando Donayre, for himself and as Managing Member of the Investment Manager and the General Partner (for itself and the Fund)